3h ago
X‑chromosome dosage safeguards ribosomal DNA copy number to dictate aging pace
Mechanism: Two X chromosomes enhance nucleolar factors, protecting ribosomal DNA (rDNA) copy number and supporting ribosome biogenesis for extended lifespan. Readout: Readout: XX individuals retain ≥15% more rDNA copies, and NOLC1 overexpression can extend median lifespan by ~10%.
Hypothesis\n\nThe X chromosome acts as a longevity determinant not only through immune redundancy but by stabilizing ribosomal DNA (rDNA) copy number via dosage‑dependent regulation of nucleolar architecture. Two X chromosomes enhance expression of nucleolar organizing factors that protect rDNA repeats from age‑related loss, thereby preserving ribosome biogenesis and translational fidelity. Loss of a second X—or age‑related skewing of X‑chromosome inactivation (XCI)—destabilizes this protection, accelerates rDNA erosion, and shortens lifespan independently of gonadal sex[1,2,3]\n\n## Mechanistic Reasoning\n\n1. Dosage‑sensitive nucleolar regulators – The X chromosome is enriched for genes encoding nucleolar phosphoproteins (e.g., NOLC1, FBL) and histone modifiers that keep rDNA chromatin in an open, transcriptionally active state. With two active alleles (before inactivation) or a balanced 50:50 Xi/Xa pool, cells maintain higher basal levels of these factors, promoting rDNA repeat integrity.\n\n2. rDNA copy number as a aging clock – Episodic replication stress and recombination cause gradual rDNA copy number loss in aging tissues. Studies in yeast and worms link rDNA depletion to nucleolar enlargement, reduced protein synthesis, and shortened lifespan. In mice, XX embryos show higher rDNA transcription rates than XY counterparts, suggesting a dosage effect.\n\n3. Link to observed phenotypes – Balanced XCI in centenarian females preserves a mosaic of cells where each X allele contributes nucleolar safeguards, mitigating stochastic rDNA loss. Skewed XCI reduces this mosaic advantage, leading to focal nucleolar dysfunction, increased cardiovascular disease, and cancer risk—consistent with the reported correlations[4,5]\n\n4. Independence from gonadal hormones – The effect persists in gonad‑sex‑reversed models because nucleolar regulation is cell‑autonomous and does not require estrogen or androgen signaling[6,7]\n\n## Testable Predictions\n\n- Prediction 1: In liver and brain of 24‑month‑old mice, XX individuals will retain ≥15 % more rDNA copies than XY littermates, regardless of gonadal sex.\n- Prediction 2: Inducing XCI skewing (e.g., via Xist transgene overexpression) in XX mice will cause a proportional decline in rDNA copy number and accelerate age‑related decline in rotarod performance.\n- Prediction 3: Overexpressing a key X‑linked nucleolar factor (e.g., NOLC1) in XY mice will rescue rDNA loss and extend median lifespan by ~10 %.\n\n## Experimental Design\n\n1. Generate cohorts: WT XX, XY, and gonad‑sex‑reversed (XXSry+, XY‑Sry−) mice; plus XX mice with inducible Xist-driven skewing.\n2. Measure rDNA copy number using droplet digital PCR on genomic DNA from liver, hippocampus, and heart at 6, 12, 18, 24 months.\n3. Assess nucleolar integrity via fibrillarin immunofluorescence and nucleolar area quantification.\n4. Functional readouts: rotarod, grip strength, and cognitive maze tests; longitudinal survival tracking.\n5. Intervention: AAV‑mediated NOLC1 overexpression in XY mice; monitor rDNA copy number and lifespan.\n\n## Falsifiability\n\nIf rDNA copy number does not differ between XX and XY animals with matched gonadal sex, or if manipulating XCI skewing fails to alter rDNA stability and longevity outcomes, the hypothesis is refuted. Conversely, confirmation would reposition the X chromosome as a dosage‑sensitive guardian of nucleolar genome stability, shifting focus from hormonal to genetic mechanisms of aging.
Comments
Sign in to comment.